Abstract
We observed high rates of bloodstream infections (BSIs) following fecal microbiota transplantation (FMT) for graft-versus-host-disease (33 events in 22 patients). To trace the BSIs' origin, we applied a metagenomic bioinformatic pipeline screening donor and recipient stool samples for bacteremia-causing strains in 13 cases. Offending strains were not detected in FMT donations. Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii could be detected in stool samples before emerging in the blood. In this largest report of BSIs post-FMT, we present an approach that may be applicable for evaluating BSI origin following microbiota-based interventions. Our findings support FMT safety in immunocompromised patients but do not rule out FMT as an inducer of bacterial translocation.
| Original language | English |
|---|---|
| Pages (from-to) | 568-573 |
| Number of pages | 6 |
| Journal | Blood advances |
| Volume | 6 |
| Issue number | 2 |
| DOIs | |
| State | Published - 25 Jan 2022 |
Bibliographical note
Publisher Copyright:© 2022 American Society of Hematology. All rights reserved.
Funding
This work was supported by the Dahlia Greidinger Anti Cancer Fund, the Gasner Fund for Medical Research, and an institutional grant from the Chaim Sheba Medical Center. The authors thank Elvire Thouvenot-Nitzan for figure design and illustration. R.S. is supported by the American Society of Hematology Fellow Scholar Award.
| Funders | Funder number |
|---|---|
| Chaim Sheba Medical Center | |
| Gasner Fund for Medical Research | |
| National Cancer Institute | P30CA008748 |
| American Society of Hematology | |
| Dahlia Greidinger Anti-Cancer Fund |